Healthcare | Mergers & Acquisitions

Immucor Acquires Division of Biopool

Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
Immucor retained TM Capital as financial advisor to assist in an acquisition program which would build the company’s position in the transfusion diagnostics marketplace
TM Capital assisted Immucor in negotiating the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)

See Press Release

has acquired the BCA product line from

Immucor Acquires Division of Biopool

TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)

For more information, contact our healthcare team at:

healthcare@tmcapital.com

Client Testimonial

”